🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Joshua D. Palmer, MD ESTRO Sapienza Università di Roma yes.. I didn't think about it... I like too

Check out the latest paper from the Intl Radiosurgery Research Foundation showing excellent LC 89% at 1 year with only 3% ARE. SRS is an excellent option for GYN brain metastasis. pubmed.ncbi.nlm.nih.gov/40622139/

📝New publication from Dr. Sameek Roychowdhury & colleagues: Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers npj Journals doi.org/10.1038/s41698…

Check out the real world analysis of brain metastasis development after durva. The team four a 16.6% which is higher than in the reported trials. Great work Dwight Owen and team!! sciencedirect.com/science/articl…

¹⁷⁷Lu-DOTATATE is cost-effective as a first-line treatment for patients with grade 2 or 3, well-differentiated, advanced gastroenteropancreatic #NeuroendocrineTumors. ow.ly/Zzw150W9YMP #NuclearMedicine Wolfgang Kunz Marcus Unterrainer MatthiasBrendel LenaUnterrainer

There's still time to register and join us tomorrow (7/9) for the #ASNR and #ASFNR webinar. Join us at 1:00 pm ET (note the different time) for Seeing The Invisible: PET/MRI Advancements in Brain Tumor Evaluation (Presented by ASNR and ASFNR). Register: ow.ly/kWgK50WgMyI

Looking forward to this discussion with some of my favorite #braintumor #PET #imaging experts! Honored to be a part of this panel. Hope to see many of you there #radtwitter Weill Cornell Medicine Radiology Weill Cornell Medicine's Radiology Residents WCM Molecular Imaging and Therapeutics Weill Cornell Medicine The American Society of Neuroradiology SNMMI

Great work from the FETS challenge Spyridon Bakas demonstrating the real world algorithmic performance evaluation of diverse multi parametric data. Similar multi site setups can help validate. Important AI competition and group publication. pubmed.ncbi.nlm.nih.gov/40628696/

Incredible #RadOnc Grand Rounds Mass General Cancer Center by Dr. Jona Hattangadi-Gluth Jona Hattangadi-Gluth, MD on oncofunctional balance in brain tumors—from connectomics to clinical trials. Loved the focus on neuroimaging biomarkers, cognitive-sparing therapies, and the future of precision radiation

Was super excited to start using Dexcom #stelo to pair with the OURA4, only to find out the device won’t pair after hours of troubleshooting. Highly don’t recommend, maybe after a few more years they can work out the bugs for a working device for everyday use.

Myrsini Ioakeim-Ioannidou, MD Mass General Cancer Center Thank you for having me! It was a blast to see so many friends and colleagues and I look forward to future collaborations 🧠 MGH will always be family ❤️

Joshua D. Palmer, MD Myrsini Ioakeim-Ioannidou, MD Mass General Cancer Center Thanks Josh! Excited to hear about your work next month at SNO/ASCO

Prospective study of stereotactic radiation for treatment of brain metastases (1-10) in SCLC (instead of whole brain radiation) Journal of Clinical Oncology. In 100 pts (median number of metastases was 2), only 22% of pts required salvage WBRT, mOS 10.2m. ascopubs.org/doi/10.1200/JC…

Very important and will be great to see results of NRG Oncology CC-009 on this topic!

Gynecological Cancer metastatic to the brain. Delighted to join Dr. Mathieu and colleagues in this international, multicenter study published in Neurosurgery.

Proud to share that Ohio State's Radiation Oncology Residency Program is now ranked #16 nationally in the 2025 @Doximity rankings! 📈 Grateful to our team, leaders, and educators for their unwavering commitment to excellence in training and patient care. #RadOnc #OSU

Yuan James Rao I’ve tried it for refractory tracheitis after “gomezable M0” lung 52.5/15 with 60 Gy dmax in setting of history of true anaphylaxis to steroids Of course correlation doesn’t mean causation but it worked well for them and recurred when they stopped it, got better upon resumption

👇Having treated multiple patients who developed radionecrosis after SRS for brain mets or after IMRT for high-grade gliomas, I can attest - Boswellia (4,000 - 4,500 mg/day) works! And the best part is that it is an over-the-counter (or over-the-Amazon!) herbal supplement.